… Read More
BOSTON, Oct. 14, 2020 /PRNewswire/ — Orbita, the leading provider of HIPAA-compliant conversational voice and chat solutions for healthcare and life science organizations, today launched a new module designed to help pharmaceutical companies better detect and report adverse events. The new platform-agnostic Adverse Event module, built on the latest technology in machine learning and natural language processing, integrates into existing chat services to accurately detect and seamlessly assist users in reporting adverse reactions to medications, ultimately improving the efficiency and timeliness of adverse event reporting.
Machine learning fuels seamless and accurate reporting
Chatbots are an increasingly popular tool for patient support programs, but few are equipped to accurately flag if a patient is having a medication-induced side effect, which can hinder pharmacovigilance processes and success. Orbita’s new Adverse Event module draws from a robust corpus of medical and conversational data, while machine learning continually improves the module to increase
Law360 (September 22, 2020, 5:45 PM EDT) — The U.S. Department of the Treasury published a final rule on Sept. 15, revising provisions in the regulations of the Committee on Foreign Investment in the United States that implement Section 721 of the Defense Production Act, as amended by the Foreign Investment Risk Review Modernization Act of 2018.
The rule becomes effective Oct. 15, and once in place, will do away with the critical technology mandatory declaration based on North American Industry Classification System codes, which are applicable to U.S. businesses in one of 27 industries, that were part of a rule published Jan. 17.
In that rule, the Treasury…
… Read More
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the
… Read More
Well, that was fast.
This morning, I analyzed Palantir’s newly published 5th amendment of its S-1 filing with the SEC as it pursues a public direct listing on the NYSE. I called the company “not a democracy” after it added new provisions to create a special mechanism called “Stockholder Party Excluded Shares” that would, in the language of Palantir, allow the company’s trio of founders to “unilaterally adjust their total voting power” at will, now and into the future.
Well, Palantir has now filed a 6th amendment with the SEC just a few hours after it filed its previous amendment, and the company has removed all references to this special mechanism from its SEC filing.
The 19 mentions of “Stockholder Party Excluded Shares” and multiple sections where the mechanism were discussed and explained have now been entirely excised. In addition, the company’s line about its founders having the capability to